49 results
8-K
CERE
Cerevel Therapeutics Holdings Inc
16 Feb 24
Submission of Matters to a Vote of Security Holders
4:46pm
to retain and hire key personnel, or its operating results and business generally.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
DEFA14A
CERE
Cerevel Therapeutics Holdings Inc
9 Feb 24
Additional proxy soliciting materials
9:00am
or other expenses; (vi) the effect of the announcement or pendency of the proposed Merger on Cerevel’s ability to retain and hire key personnel
DEFM14A
vjbnhryj2i
18 Jan 24
Proxy related to merger
7:44am
PRER14A
utnop2t26
18 Jan 24
Preliminary revised proxy
7:19am
PREM14A
e83yytfdq6
5 Jan 24
Preliminary proxy related to merger
5:13pm
DEFA14A
vroveva1rwgwsa
7 Dec 23
Additional proxy soliciting materials
8:02am
8-K
EX-99.2
sto g17l6t97b
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-2.1
n05 9t7ht0
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
5b3l1ah75784q5y
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am